Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Wells A. Messersmith
Antonio Jimeno
David Ettinger
Dan Laheru
Julie Brahmer
Dina Lansey
Yasmin Khan
Ross C. Donehower
Yusri Elsayed
Peter Zannikos
Manuel Hidalgo
机构：
[1] University of Colorado Cancer Center,
[2] Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,undefined
[3] Johnson & Johnson Pharmaceutical Research & Development,undefined
[4] L.L.C.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词：
Dose-finding; Phase I; Gemcitabine; Pharmacokinetics; Trabectedin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 188
页数：7
相关论文
共 50 条
  • [41] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [42] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [43] Phase I clinical study of ecteinascidin-743 (ET-743) as a 24 hours continuous intravenous infusion (CI) in patients (pts) with solid tumors (st): A progress report
    Taamma, A
    Cvitkovic, E
    Jimeno, J
    Gasparetto, M
    Meeley, K
    Vega, E
    Cameron, L
    Misset, JL
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1119 - 1119
  • [44] A phase I and pharmacokinetic (PK) study of ET-743 evaluating a 3 hours (h) intravenous (iv) infusion (I) in patients (pts) with solid tumors.
    Twelves, C
    Hoeckman, H
    Bowman, A
    Beijnen, JH
    Faber, M
    Guzman, C
    Anthoney, A
    Smyth, J
    Hanauske, AR
    Jimeno, J
    CLINICAL CANCER RESEARCH, 1999, 5 : 3790S - 3791S
  • [45] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
  • [46] Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors
    Bolling, C
    Lubbing, C
    Graefe, T
    Mack, S
    Von Scheel, J
    Muller-Hagen, S
    Blatter, J
    Depenbrock, H
    Ohnmacht, U
    Hanauske, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 218S - 218S
  • [47] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Costello, Brian A.
    Borad, Mitesh J.
    Qi, Yingwei
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 710 - 716
  • [48] A phase II study of trabectedin (ET-743) as a second line therapy in patients with persistent or recurrent endometrial carcinoma.
    McMeekin, DS
    Manikas, G
    Crispens, M
    Orza, AM
    Braly, P
    Doering, D
    Trifan, OC
    Michiels, B
    Markman, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 470S - 470S
  • [49] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Vidal, Laura
    Magem, Margarita
    Barlow, Clare
    Pardo, Beatriz
    Florez, Amalia
    Montes, Ana
    Garcia, Margarita
    Judson, Ian
    Lebedinsky, Claudia
    Kaye, Stan B.
    Salazar, Ramon
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 616 - 628
  • [50] Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors
    Laura Vidal
    Margarita Magem
    Clare Barlow
    Beatriz Pardo
    Amalia Florez
    Ana Montes
    Margarita Garcia
    Ian Judson
    Claudia Lebedinsky
    Stan B. Kaye
    Ramón Salazar
    Investigational New Drugs, 2012, 30 : 616 - 628
12345